Penglin Zhou, Rui Gao, Anan Li, Xichao Wu, Yanjiao Zhu, Shuai He et al. Cost-utility of injectable and oral GLP-1RAs for type 2 diabetes mellitus inadequately controlled with metformin: A Markov model analysis. // Pharmacoeconomics and Policy. – 2026. – DOI: 10.1016/j.pharp.2026.08.004. – URL: https://doi.org/10.1016/j.pharp.2026.08.004
Penglin Zhou, Rui Gao, Anan Li, Xichao Wu, Yanjiao Zhu, Shuai He, Yan Li, & Rui Yang (2026). Cost-utility of injectable and oral GLP-1RAs for type 2 diabetes mellitus inadequately controlled with metformin: A Markov model analysis. Pharmacoeconomics and Policy. https://doi.org/10.1016/j.pharp.2026.08.004
Penglin Zhou, et al. “Cost-utility of injectable and oral GLP-1RAs for type 2 diabetes mellitus inadequately controlled with metformin: A Markov model analysis.” Pharmacoeconomics and Policy, 2026. doi:10.1016/j.pharp.2026.08.004.
@article{Zhou2026,
title = {Cost-utility of injectable and oral GLP-1RAs for type 2 diabetes mellitus inadequately controlled with metformin: A Markov model analysis},
author = {Zhou, Penglin and Gao, Rui and Li, Anan and Wu, Xichao and Zhu, Yanjiao and He, Shuai and Li, Yan and Yang, Rui},
journal = {Pharmacoeconomics and Policy},
year = {2026},
doi = {10.1016/j.pharp.2026.08.004},
url = {https://doi.org/10.1016/j.pharp.2026.08.004}
}